Comparison of the mortality observed with that expected from mortality rates in the general population indicated three times the expected number of deaths from nonneoplastic causes. Five times the expected number of deaths from cardiovascular causes were observed, these were predominantly myocardial infarction and cerebrovascular accidents. There was no evidence of an excess in the number of suicides observed, but there were three times the expected number of deaths from accidents observed after central nervous system tumours.
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Abstract An investigation of 749 deaths occurring among 4082 patients surviving at least five years after the diagnosis of childhood cancer in Britain before 1971 has been undertaken. Of the 738 with sufficient information the numbers of deaths attributable to the following causes were: recurrent tumour, 550 (74%), a second primary tumour, 61 (8%), a medical condition related to treatment of the tumour, 49 (7%), an traumatic death unrelated to the tumour or its treatment, 34 (5%), finally, any other cause unrelated to the tumour or its treatment, 44 (6%).
Less than 10% of five year survivors of non-Hodgkin lymphomas, neuroblastoma, retinoblastoma, Wilms' tumour, or a soft tissue sarcoma died of recurrent tumour during the next 15 years, while more than 25% of five year survivors of Hodgkin's disease, ependymoma, medulloblastoma, and Ewing's tumour died of recurrent tumour during the corresponding period. Almost 50% of five year survivors of acute lymphoblastic leukaemia died of recurrent disease during the corresponding 15 years, a large proportion of deaths being due to central nervous system relapse in an era before central nervous system prophylaxis was routinely given.
Comparison of the mortality observed with that expected from mortality rates in the general population indicated three times the expected number of deaths from nonneoplastic causes. Five times the expected number of deaths from cardiovascular causes were observed, these were predominantly myocardial infarction and cerebrovascular accidents. There was no evidence of an excess in the number of suicides observed, but there were three times the expected number of deaths from accidents observed after central nervous system tumours.
Two groups of patients were identified whose deaths were potentially avoidable.
Seven patients with craniopharyngioma and panhypopituitarism presented with addisonian crises during periods of stress not adequately covered by exogenous corticosteroids. In the other group were children who received radiotherapy and later developed problems related to radiation fibrosis.
We emphasise that our investigation relates to patients diagnosed with childhood cancer before 1971 . The pattern of mortality that will emerge after recent treatment regimens, in which chemotherapy is being used more extensively, is likely to be different from that observed in our study.
Examination of the course of events leading to death among patients who survive at least five years after childhood cancer is important as it may provide further understanding of late relapse and the late effects of treatment. With the benefit of hindsight it may be possible to identify deaths that might have been preventable. If the study population is large it is likely that deaths from rare adverse consequences of the neoplastic disease or its treatment will be identified. Such an investigation requires clinical information relating to the circumstances of death and therefore access to sources other than the death certificates, including hospital records and reports from postmortem examination.
A comparison of the mortality observed with that expected from mortality in the general population, for specific causes of death-both neoplastic and non-neoplastic-may also provide further insight into the curability of childhood neoplastic disease and identify any departure from the expected pattern of mortality. For this type of comparison it is necessary to rely on death certification because the expected numbers are derived from general population rates which are themselves based on death certificates alone. This paper is complementary to our previous report on long term A consequence of restricting the study to this period of diagnosis is that we are primarily concerned with malignant disease that was amenable to treatment with radiation and surgery, as apart from the treatment of leukaemia, cytotoxics were not in widespread use before 1971. An advantage of studying this period, however, is that sufficient time has elapsed to examine late mortality. A few conventions were used in coding deaths into these broad categories. In patients with tumours of the central nervous system, the cause of death given on the death certificate was frequently bronchopneumonia. Examination of the case records of a number of these patients showed that their general health had gradually declined, the patients had become obtunded due to recurrent tumour and had eventually died from bronchopneumonia. These deaths were all coded as recurrent tumour rather than infection. When death occurred from infections such as herpes zoster, meningitis, or pneumonia in patients on chemotherapy then they were coded as a death from a medical condition related to treatment of the tumour. One patient with Hodgkin's disease who had undergone a splenectomy and had subsequently died from a pneumococcal septicaemia, while in remission, was also coded to a medical condition related to treatment. When death occurred from infection or other cause and where there was insufficient evidence to determine whether the patient had active disease at the time, then the death was coded to insufficient information.
For the purposes of comparing the mortality observed with that expected we also recorded the International Classification of Diseases (ICD) code appearing on the death certificate. We restricted the study to revisions 6, 7, 8 The number of patients who survive to a specified time does not equal the number surviving in the previous time interval plus deaths in the interim *Medical condition related to treatment of the tumour.
tTraumatic death unrelated to tumour or its treatment-that is, accident, suicide, or homicide.
tAny other cause unrelated to tumour or its treatment. phoblastic leukaemia and exceeded 10 extra deaths per 100 patients per year. Table 7 , again using information from death certificates only, gives the results of comparing the observed and expected number of deaths from all causes other than neoplasm. Threefold the expected number of non-neoplastic deaths were observed. We observed 13-fold the number of deaths expected from infections other than pneumonia and influenza. The excess of deaths assigned to pneumonia and influenza, particulary after central nervous system tumours, needs careful interpretation because of the tendency of many clinicians to record bronchopneumonia as the cause of death in patients with recurrent tumours of the central nervous system, but may also reflect the problem of prolonged impairment of immunity in patients with a history of cancer. Of the eight Hodgkin's disease Table 7 Comparison of observed and expected deaths from non-neoplastic causes five or more years from diagnosis There was fivefold excess of deaths from congenital causes as coded from the death certificate. Of the six deaths thus coded, three were in patients with von Recklinghausen's disease, one of the patients dying from renal failure which was tumour related and two from recurrent tumour. There were two further deaths from renal failure, one in a patient with Wilms' tumour and polycystic kidneys and one in a patient with neuroblastoma and spina bifida who had a neurogenic bladder and hydronephrosis. The final death in this category was due to mechanical failure of an aortic valve prosthesis in a patient with congenital heart disease.
Considering all neoplasms as a single group there was no evidence of an excess of deaths from suicides. The excess of deaths from accidents other than medical misadventure was predominantly due to observing threefold the expected number of accidents after tumours of the central nervous system. A total of 11 patients who had been treated for these tumours died from accidents. Six of these patients (aged 10 to 35) died in road traffic accidents, two teenagers died from burns caused by accidental fires and hot water scalds at home, and two patients from complications after falls. The final death was due to manual strangulation, but in what circumstances this occurred is uncertain. Apart from one child with an optic nerve glioma who was visually handicapped we can only speculate that the effect of the tumour or treatment had resulted in some sensory or intellectual impairment that increased the risk of these patients becoming involved in accidents.
Discussion
Ascertaining the cause of death in a population of children who were diagnosed before 1971 was not easy as some hospitals destroy medical records at a specified number of years after death, and even when records were available, it was sometimes difficult to be completely sure of the actual cause of death. Fortunately, in the present study, we obtained hospital notes or a postmortem examination report for 80% of the deaths from causes other than recurrent tumour. We were most confident of our assessment where a postmortem examination report was available.
The 8 Our study indicates that in children with central nervous system tumours, deaths from recurrent tumour were still occurring more than 20 years from diagnosis. Many central nervous system tumours, particularly low grade astrocytomas and craniopharyngiomas, are relatively slow growing and so deaths may occur many years after the initial diagnosis. It is also recognised that both Hodgkin's disease and Ewing's tumour are indolent tumours and multiple relapses responding to further treatment can occur over a period of several years before eventual death from disease occurs.
The high frequency of deaths from recurrent disease after acute lymphoblastic leukaemia is partly explained by a large number of central nervous system relapses occurring during an era when children were not routinely given central nervous system irradiation and intrathecal methotrexate to reduce the risk of meningeal leukaemia. Central nervous system leukaemia may take a very indolent course, being partially controlled for long periods, and it may be several years before either a subsequent bone marrow relapse occurs or the child develops resistant central nervous system disease. In addition, some children with meningeal leukaemia may develop an encephalopathy from the combination of repeated cranial irradiation and intrathecal methotrexate and this may not become manifest until several years after treatment.
In our study second primary tumours as a cause of death were relatively more commonly seen in patients with genetic retinoblastoma and Wilms' tumour. We have reported on the pattern and incidence of second primary tumours among survivors of childhood cancer elsewhere.9 10 Of the 49 deaths from causes related to treatment, at least 21 occurred in children undergoing treatment for recurrent disease and these deaths were probably unavoidable due to the intensity of treatment required in the presence of resistant disease. However, it is possible that a number of the remaining 28 deaths might have been preventable. The main cause of potentially avoidable death was from endocrine failure (n= 7) in children with craniopharyngioma and panhypopituitarism who presented with addisonian crises in periods of stress related to infection. It is possible that the need for high doses of intravenous corticosteroids, which might have been life saving, was not recognised in these cases.
The other major cause of death related to primary treatment was from problems secondary to post radiation fibrosis. Five ranged from 2 to 20 mg/100 ml (34 to 340 [imol/ 1). Babies with concentrations over 7 mg/100 ml (119 ,umol/l) at birth seldom recovered.
Treatment was simple transfusion of Rh negative blood in quantities of 15 ml/pound body weight, repeated as necessary. At first the anterior fontanelle was used, then the saphenous vein at the ankle, and only in the later cases was transfusion given by the umbilical vein. Of 35 babies treated by simple transfusion 17 died. The author reported that a new transfusion technique (exchange transfusion) was being tried at the time of writing but that the early results were less satisfactory than had been anticipated.
Kernicterus did not develop in any baby before the age of 18 hours but was present in 37 (34%) of the cases of severe jaundice. The serum bilirubin concentrations in babies with kernicterus ranged from 10 to 20 mg/100 ml (170 to 340 ,imol/l). All but two of the babies with kernicterus died: 33 within two weeks of birth. Four babies survived beyond the age of 2 weeks: two died in infancy and two survived to develop cerebral palsy.
